Related Experiment Video
Updated: Feb 23, 2026
08:07
A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
3.1K
Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development
Tatiana I Samoylova1,2, Timothy D Braden3, Jennifer A Spencer2
1Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA.
Current Medicinal Chemistry
|September 14, 2017
Summary
Filamentous bacteriophages offer a safe, cost-effective platform for developing contraceptive vaccines in animals. These phage-based vaccines are stable, immunogenic, and adaptable for controlling animal populations.
Area of Science:
- Veterinary immunology
- Vaccine technology
- Molecular biology
Background:
- Population control in animals is a global challenge impacting public health and welfare.
- Effective, safe, and affordable contraceptive methods are urgently needed.
- Contraceptive vaccines stimulating the immune system offer a potential solution.
Purpose of the Study:
- To review the structural and immunogenic properties of filamentous phages.
- To discuss the use of phage-peptide vaccines for advancing animal immunocontraception.
Main Methods:
- Engineering phages to display foreign peptides as coat proteins via genetic modification or chemical conjugation.
- Evaluating the immunogenicity of phage fusions in animal models.
- Assessing phage platform characteristics like stability and cost.
Main Results:
- Phage engineering allows display of antigenic determinants, inducing humoral and cell-mediated immune responses.
- Phage-based vaccines are environmentally stable, inexpensive, and safe.
- These characteristics make phages attractive for vaccine development.
Conclusions:
- Filamentous phages are versatile platforms for developing specific, cost-effective, and stable vaccines.
- Phage vaccines are suitable for practical animal immunocontraception due to abundance, low cost, and stability.
- The phage platform's adaptability also supports potential human immunocontraceptive applications.
Related Concept Videos
01:26DNA Bacteriophages
1.1K
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
1.1K
01:30Lytic Cycle of Bacteriophages
78.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
78.4K
00:43Lysogenic Cycle of Bacteriophages
68.2K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
68.2K
02:53CRISPR and crRNAs
19.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.3K
01:16Viral Replication: Lysogenic Cycle
1.9K
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
1.9K
01:29Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K